2m 2m 2m 2m 2m 2m 2m
ALIGOS THERAPT (ALGS)
NASDAQ
$5.70+$0.20 (+3.62%)
Price as of Oct 02, 2026 7:30 PM EDT- $29.9MMarket Cap
- -46.29%1-Year Change
- BiotechnologyIndustry
ALIGOS THERAPT (ALGS)
$5.70+$0.20 (+3.62%)
ALGS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.50 | ||
Change | -$0.13 (-2.31%) | ||
Open | $5.69 | ||
High | $5.74 | ||
Low | $5.37 | ||
Previous Close | $5.63 | ||
Volume | 28,258 | ||
30-Day Average Volume | 47,377 | ||
1-Week Change | -0.90% | ||
1-Month Change | -9.69% | ||
1-Year Change | -46.29% | ||
3-Year Change | -70.55% | ||
5-Year Change | -98.59% | ||
Fundamentals | |||
Shares Outstanding | 5.4M | ||
Total Assets | $66.3M | ||
Market Cap | $29.9M | ||
Enterprise Value | -$435,931.00 | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$1.5M | ||
Free Cash Flow | -$24.9M | ||
EBIT | $1.3M | ||
EBITDA | $1.6M | ||
Net Working Capital | $33.8M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -39 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/19/2024 | ||
Earnings & Revenue